New Managing Director for AMSilk GmbH
Mr. Jens Klein was appointed managing director ofAMSilk GmbH, Planegg. He succeeds Mr. Axel Leimer, AMSilk’s former CEO, who had successfully run the company for six years until February 28, 2014. As CEO Mr. Klein is responsible for the strategic positioning and the future growth of the company.
Most recently Mr. Klein worked for Evonik Industries AG. In 2011 Evonik acquired nanoresins AG and Hanse Chemie AG. Mr. Klein was a member of the executive committee of both companies since 2006. In these functions he had a significant impact on the growth of both companies, the integration of new technologies, the optimization of manufacturing processes as well as the international expansion.
Previously, he was a member of the executive board of Mulligan BioCapital AG, Hamburg and Munich. Mulligan used to be a long-term investor in medical technology, biotechnology and high technology enterprises in the US and Europe. Among other responsibilities Mr. Klein shared responsibilty for the initial public offerings of two portfolio companies as well as several trade sales to strategic investors. Prior to joining Mulligan he was the commercial head and managing director of subsidiaries of Fresenius AG, Bad Homburg.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
